ADVANCE Trial: PEG-IFN-β-1a Every 2 Weeks Significantly Improved Outcomes over 2 Years in RRMS

Article Information

DOI 
http://dx.doi.org/10.1177/155989771429004
Published By 
SAGE Publications
Print ISSN 
1559-8977
Online ISSN 
2155-756X
Copyright & Usage 
© 2014 MD Conference Express®

Author Information

  1. Toni Rizzo
  1. Douglas L. Arnold, MD
    1. NeuroRX Research and Montreal Neurological Institute, McGill University, Montreal, Québec, Canada
View Full Text

Article usage

AbstractFullPDF
Apr 2015800
May 2015201
Jun 20152000
Jul 2015100
Aug 2015400
Sep 2015300
Oct 2015232
Nov 2015011
Total4044

Note: Article usage statistics are calculated and reported monthly.

Cited By...

  • No citing articles found.
Back to top

Tools

View Full Page PDF
Citation Tools
Email
ADVANCE Trial: PEG-IFN-β-1a Every 2 Weeks Significantly Improved Outcomes over 2 Years in RRMS
Permalink: Copy
Linkedin Share Button del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo StumbleUpon logo

Table of contents

Cited By...

  • No citing articles found.

Keywords

Neuroimaging
Demyelinating Diseases
Magnetic Resonance Imaging
Neurology Clinical Trials
Neurology
Neuroimaging
Demyelinating Diseases
Magnetic Resonance Imaging
Neurology Clinical Trials